Arthur M. Friedlander

Publications

• Human Innate Immune Cells Respond Differentially to Poly-γ-Glutamic Acid Polymers from and Nonpathogenic Species
  Journal of Immunology (Baltimore, Md. : 1950). Mar, 2020  |   Pubmed ID: 31932496
• Formaldehyde and Glutaraldehyde Inactivation of Bacterial Tier 1 Select Agents in Tissues
  Emerging Infectious Diseases. 05, 2019  |   Pubmed ID: 30681072
• Green Tea and Epigallocatechin-3-gallate Are Bactericidal Against Bacillus Anthracis
  FEMS Microbiology Letters. Jul, 2017  |   Pubmed ID: 28605495
• PH Alkalinization by Chloroquine Suppresses Pathogenic Burkholderia Type 6 Secretion System 1 and Multinucleated Giant Cells
  Infection and Immunity. Jan, 2017  |   Pubmed ID: 27799332
• Protection of Rhesus Macaques Against Inhalational Anthrax with a Bacillus Anthracis Capsule Conjugate Vaccine
  Vaccine. Jul, 2016  |   Pubmed ID: 27329184
• Exposure to Bacillus Anthracis Capsule Results in Suppression of Human Monocyte-derived Dendritic Cells
  Infection and Immunity. Aug, 2014  |   Pubmed ID: 24891109
• Efficacy of a Capsule Conjugate Vaccine Against Inhalational Anthrax in Rabbits and Monkeys
  Vaccine. Jan, 2012  |   Pubmed ID: 22172509
• Capsule Depolymerase Overexpression Reduces Bacillus Anthracis Virulence
  Microbiology (Reading, England). May, 2010  |   Pubmed ID: 20110296
• Advances in the Development of Next-generation Anthrax Vaccines
  Vaccine. Nov, 2009  |   Pubmed ID: 19837282
• Treatment of Experimental Anthrax with Recombinant Capsule Depolymerase
  Antimicrobial Agents and Chemotherapy. Mar, 2008  |   Pubmed ID: 18160516
• Microarray Analysis of Transposon Insertion Mutations in Bacillus Anthracis: Global Identification of Genes Required for Sporulation and Germination
  Journal of Bacteriology. Apr, 2007  |   Pubmed ID: 17277068
• Poly-gamma-glutamate Capsule-degrading Enzyme Treatment Enhances Phagocytosis and Killing of Encapsulated Bacillus Anthracis
  Antimicrobial Agents and Chemotherapy. Jan, 2007  |   Pubmed ID: 17074794
• Short-course Postexposure Antibiotic Prophylaxis Combined with Vaccination Protects Against Experimental Inhalational Anthrax
  Proceedings of the National Academy of Sciences of the United States of America. May, 2006  |   Pubmed ID: 16672361
• Construction of a Rhamnose Mutation in Bacillus Anthracis Affects Adherence to Macrophages but Not Virulence in Guinea Pigs
  Microbial Pathogenesis. Jan, 2005  |   Pubmed ID: 15652290
• The NheA Component of the Non-hemolytic Enterotoxin of Bacillus Cereus is Produced by Bacillus Anthracis but is Not Required for Virulence
  Microbial Pathogenesis. Sep, 2004  |   Pubmed ID: 15351038
• Antibody Response to a Delayed Booster Dose of Anthrax Vaccine and Botulinum Toxoid
  Vaccine. May, 2002  |   Pubmed ID: 11972980
• Anthrax Vaccine: Immunogenicity and Safety of a Dose-reduction, Route-change Comparison Study in Humans
  Vaccine. Jan, 2002  |   Pubmed ID: 11818160
• Vaccination Against Anthrax with Attenuated Recombinant Strains of Bacillus Anthracis That Produce Protective Antigen
  Infection and Immunity. Feb, 1999  |   Pubmed ID: 9916059
• Antibiotic Treatment of Experimental Pneumonic Plague in Mice
  Antimicrobial Agents and Chemotherapy. Mar, 1998  |   Pubmed ID: 9517950